Limited time75% off all plans
Get the app

Liver transplantation

On this page

Indications & Scoring - The Waiting Game

  • Indications for Transplant

    • Acute Liver Failure: Fulminant viral hepatitis (A, B), drug-induced (e.g., Acetaminophen), Wilson's disease.
    • Chronic Liver Disease: Decompensated cirrhosis from any cause (HCV, HBV, NAFLD, alcohol), Hepatocellular Carcinoma (HCC) within Milan criteria.
  • MELD Score: Prioritizes Allocation

    • Calculates 3-month mortality risk. Formula: $MELD = 3.78 imes ext{ln[Bilirubin]} + 11.2 imes ext{ln[INR]} + 9.57 imes ext{ln[Creatinine]} + 6.43$
    • 📌 Mnemonic: I Bleed Chestnuts (INR, Bilirubin, Creatinine).
  • Absolute Contraindications

    • Severe, irreversible cardiopulmonary disease.
    • Active extrahepatic malignancy.
    • Ongoing alcohol or illicit substance abuse.

⭐ Patients with a MELD score ≥ 15 are typically listed. MELD-Na is a common variant, adding sodium for better prognostication in hyponatremia.

Evolution of MELD, MELD-Na, and MELD 3.0 components

Donor & Surgery - The Main Event

  • Deceased Donor (DDLT): Whole organ from a deceased donor; longer wait times.
  • Living Donor (LDLT): Partial graft (e.g., right lobe) from a living donor; technically complex.

Liver Transplant Surgical Techniques

  • Key Early Complications:
    • Hepatic Artery Thrombosis (HAT): Most common vascular complication.
    • Portal Vein Thrombosis
    • Biliary leaks & strictures

⭐ HAT is a surgical emergency, often presenting with graft dysfunction and requiring urgent re-transplantation.

Rejection Types - The Body Fights Back

TypeOnsetPathophysiologyHistology Findings
HyperacuteMinutes to hoursPre-formed anti-donor AbsVascular thrombosis, neutrophilic infiltrate
AcuteDays to weeks (<6 mo)T-cell mediated injuryPortal lymphocytic infiltrate, endothelitis
ChronicMonths to years (>6 mo)Mixed cellular & humoralVanishing bile duct syndrome, progressive fibrosis

⭐ Acute rejection is the most common type, typically occurring within the first few months post-transplant; it is usually reversible with immunosuppressive therapy.

Immunosuppression - Taming the Guards

  • A multi-drug regimen prevents rejection by targeting different immune pathways, balancing efficacy with toxicity.
Drug ClassDrugsKey Adverse Effects
Calcineurin InhibitorsTacrolimus, CyclosporineNephrotoxicity, neurotoxicity (tremor), HTN, ↑K⁺
AntimetabolitesMycophenolate MofetilGI distress (diarrhea), bone marrow suppression
mTOR InhibitorsSirolimus, EverolimusHyperlipidemia, delayed wound healing, stomatitis
CorticosteroidsPrednisoneHyperglycemia, osteoporosis, Cushingoid features

⭐ Calcineurin inhibitors (Tacrolimus, Cyclosporine) are metabolized by CYP3A4; many drug-drug interactions can affect their levels.

Post-Op Complications - Navigating the Aftermath

  • Opportunistic Infections: Follow a predictable timeline based on the net state of immunosuppression.
  • Metabolic Syndrome: Immunosuppressants often drive new-onset diabetes, hypertension, and hyperlipidemia.
  • Renal Insufficiency: A major long-term issue, frequently due to calcineurin inhibitor (tacrolimus) nephrotoxicity.
  • Malignancy: Significantly ↑ risk of skin cancer (squamous cell) & Post-Transplant Lymphoproliferative Disorder (PTLD).

⭐ PTLD is a life-threatening B-cell proliferation driven by Epstein-Barr Virus (EBV). Reducing immunosuppression is a key first step in management.

High‑Yield Points - ⚡ Biggest Takeaways

  • MELD score is key for allocation, predicting 3-month mortality using bilirubin, INR, creatinine, and sodium.
  • Main indications are acute liver failure, decompensated cirrhosis, and HCC within Milan criteria.
  • Absolute contraindications include active extrahepatic malignancy, severe cardiopulmonary disease, and active substance abuse.
  • Post-transplant immunosuppression typically involves tacrolimus, mycophenolate, and corticosteroids.
  • Suspect acute rejection with rising LFTs; confirm with biopsy. Hepatic artery thrombosis is a major vascular complication.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE